Cargando…
Do coxibs reduce prescription of gastroprotective agents? Results of a record linkage study
BACKGROUND: Coxibs are claimed to be cost-effective drugs and reduced prescription of gastroprotective agents is assumed to be one of their major benefits. Real life prescription of these drugs may be substantially different than that considered in pharmacoeconomic analyses or claimed by drug compan...
Autores principales: | Formoso, Giulio, Menna, Angelo, Voci, Claudio, Violante, Andrea, Magrini, Nicola |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1475644/ https://www.ncbi.nlm.nih.gov/pubmed/16553942 http://dx.doi.org/10.1186/1478-7547-4-4 |
Ejemplares similares
-
Coxibs: Can this Class of Drugs Survive?
por: Tabrizchi, Reza
Publicado: (2005) -
Review of the cardiovascular safety of COXIBs compared to NSAIDS
por: Moodley, I
Publicado: (2008) -
Analysis of the Health and Budgetary Impact of Chondroitin Sulfate Prescription in the Treatment of Knee Osteoarthritis Compared to NSAIDs and COXIBs
por: Rubio-Terrés, Carlos, et al.
Publicado: (2020) -
Prescription of and Adherence to Non-Steroidal Anti-Inflammatory Drugs and Gastroprotective Agents in At-Risk Gastrointestinal Patients
por: Lanas, Angel, et al.
Publicado: (2012) -
The Pattern of Use of Oral NSAIDs with or without Co-prescription of Gastroprotective Agent for Arthritic Knee by Korean Practitioners
por: Kim, Hee-Chun, et al.
Publicado: (2011)